PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsPromethazine
Promethazine
/ Promethazine, Codeine / Phenylephrine / Promethazine, Codeine / Promethazine, Mepergan, Phenylephrine / Promethazine, Promethazine, Promethegan (promethazine) is a small molecule pharmaceutical. Promethazine was first approved as Mepergan on 1982-01-01. It is used to treat allergic conjunctivitis, allergic rhinitis perennial, anaphylaxis, motion sickness, and nausea amongst others in the USA. The pharmaceutical is active against histamine H1 receptor.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
respiratory tract diseasesD012140
otorhinolaryngologic diseasesD010038
eye diseasesD005128
skin and connective tissue diseasesD017437
immune system diseasesD007154
signs and symptoms pathological conditionsD013568
psychological phenomenaD011579
musculoskeletal and neural physiological phenomenaD055687
Trade Name
FDA
EMA
Promethazine, Promethegan (discontinued: Phenergan, Prometh, Prometh fortis, Promethacon, Promethazine, Remsed, Zipan)
Combinations
Phenylephrine promethazine, Prometh hydrochloride,phenylephrine w/codeine, Promethazine, Promethazine codeine, Promethazine dextromethorphan, Promethazine hydrochloride,phenylephrine w/codeine, Promethazine phenylephrine, Promethazine w/ dextromethorphan, Promethazine with codeine (discontinued: Mepergan, Phenergan, Phenylephrine promethazine, Pherazine, Prometh, Promethazine, Promethazine codeine, Promethazine dextromethorphan, Promethazine hydrochloride, phenylephrine w/codeine)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Promethazine hydrochloride
Tradename
Company
Number
Date
Products
PROMETHAZINE HYDROCHLORIDE PLAINANI PharmaceuticalsN-008381 DISCN1982-01-01
2 products, RLD
PHENERGANDelcor AssetN-007935 DISCN1982-01-01
3 products, RLD
PHENERGANMylanN-010926 DISCN1982-01-01
2 products, RLD
PHENERGANMylanN-011689 DISCN1982-01-01
1 products, RLD
PHENERGANWyethN-008857 DISCN1982-01-01
2 products
Hide discontinued
Codeine phosphate
+
Promethazine hydrochloride
Tradename
Company
Number
Date
Products
PHENERGAN W/ CODEINEANI PharmaceuticalsN-008306 DISCN1984-04-02
1 products, RLD
Hide discontinued
Codeine phosphate
+
Phenylephrine hydrochloride
+
Promethazine hydrochloride
Tradename
Company
Number
Date
Products
PHENERGAN VC W/ CODEINEANI PharmaceuticalsN-008306 DISCN1984-04-02
1 products, RLD
Hide discontinued
Phenylephrine hydrochloride
+
Promethazine hydrochloride
Tradename
Company
Number
Date
Products
PHENERGAN VCANI PharmaceuticalsN-008604 DISCN1984-04-02
1 products, RLD
Hide discontinued
Dextromethorphan hydrobromide
+
Promethazine hydrochloride
Tradename
Company
Number
Date
Products
PROMETHAZINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDEANI PharmaceuticalsN-011265 RX1984-04-02
1 products, RLD
Meperidine hydrochloride
+
Promethazine hydrochloride
Tradename
Company
Number
Date
Products
MEPERGANHikma PharmaceuticalsN-011730 DISCN1982-01-01
1 products
Hide discontinued
Labels
FDA
EMA
Brand Name
Status
Last Update
dextromethorphan hydrobromide and promethazine hydrochlorideANDA2024-06-05
phenadozANDA2021-03-01
phenerganANDA2024-08-09
prometh with codeineANDA2012-01-24
promethazineANDA2022-10-08
promethazine and codeineANDA2009-08-21
promethazine dmANDA2020-12-16
promethazine hciANDA2024-02-22
promethazine hclANDA2019-11-26
promethazine hcl promethazine hydrochloride2006-11-27
Show 18 more
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
D: Dermatologicals
D04: Antipruritics, incl. antihistamines, anesthetics, etc.
D04A: Antipruritics, incl. antihistamines, anesthetics, etc.
D04AA: Antihistamines for topical use
D04AA10: Promethazine
R: Respiratory system drugs
R06: Antihistamines for systemic use
R06A: Antihistamines for systemic use
R06AD: Phenothiazine derivatives, systemic antihistamines
R06AD02: Promethazine
R06AD52: Promethazine, combinations
V: Various drug classes in atc
V03: All other therapeutic products
V03A: All other therapeutic products
V03AB: Antidotes
V03AB05: Prednisolone and promethazine
HCPCS
Code
Description
J2180
Injection, meperidine and promethazine hcl, up to 50 mg
J2550
Injection, promethazine hcl, up to 50 mg
Q0169
Promethazine hydrochloride, 12.5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
Clinical
Clinical Trials
434 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
NauseaD009325HP_0002018R11.0256720
HeadacheD006261HP_0002315R512447419
VomitingD014839HP_0002013R11.1254617
Migraine disordersD008881EFO_0003821G431345416
Sleep initiation and maintenance disordersD007319F51.011232412
PruritusD011537HP_0000989L292412310
Chronic hepatitis bD019694EFO_0004239B18.115118
HepatitisD006505HP_0012115K75.915118
DepressionD003863F33.9111148
Kidney transplantationD0160302617
Show 63 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
LymphomaD008223C85.98151124
Multiple myelomaD009101C90.06113120
NeoplasmsD009369C80513119
Plasma cell neoplasmsD0542195103118
PainD010146EFO_0003843R52325414
Healthy volunteers/patients101314
Non-hodgkin lymphomaD008228C85.9491114
Lung neoplasmsD008175HP_0100526C34.9036512
SyndromeD013577162311
Breast neoplasmsD001943EFO_0003869C50362211
Show 68 more
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
LeukemiaD007938C951112224
Precursor cell lymphoblastic leukemia-lymphomaD05419856111
Lymphoid leukemiaD007945C9146111
Hematologic neoplasmsD0193371618
Hepatitis bD0065091528
Hepatitis aD006506EFO_0007305B151517
B-cell lymphomaD016393437
Alzheimer diseaseD000544EFO_0000249F03347
Myeloid leukemia acuteD015470C92.0436
Myeloid leukemiaD007951C92426
Show 127 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Covid-19D000086382314
MalnutritionD044342EFO_0008572E40-E4633
FeverD005334HP_0001945R50.922
Alcohol-related disordersD019973F10112
HypotensionD007022EFO_0005251I9511
Pure autonomic failureD05497011
Orthostatic hypotensionD007024I95.111
Systemic mastocytosisD034721C96.2111
Oral lichen planusD01767611
Lichen planusD008010L4311
Show 33 more
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Sleep wake disordersD012893G4755
Wounds and injuriesD014947T14.833
DyssomniasD02092033
ParasomniasD020447G47.533
DeliriumD003693R41.022
InfectionsD007239EFO_000054422
Communicable diseasesD00314122
Chronic painD059350HP_001253222
Suicidal ideationD059020EFO_0004320R45.85122
Rotator cuff injuriesD000070636M75.122
Show 44 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common namePromethazine
INNpromethazine
Description
Promethazine is a tertiary amine that is a substituted phenothiazine in which the ring nitrogen at position 10 is attached to C-3 of an N,N-dimethylpropan-2-amine moiety. It has a role as a H1-receptor antagonist, a sedative, an antiemetic, a local anaesthetic, an antipruritic drug, an anti-allergic agent and an anticoronaviral agent. It is a member of phenothiazines and a tertiary amine. It is a conjugate base of a promethazine(1+).
Classification
Small molecule
Drug class
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
CC(CN1c2ccccc2Sc2ccccc21)N(C)C
Identifiers
PDB
CAS-ID60-87-7
RxCUI
ChEMBL IDCHEMBL643
ChEBI ID8461
PubChem CID4927
DrugBankDB01069
UNII IDFF28EJQ494 (ChemIDplus, GSRS)
Target
Agency Approved
HRH1
HRH1
Organism
Homo sapiens
Gene name
HRH1
Gene synonyms
NCBI Gene ID
Protein name
histamine H1 receptor
Protein synonyms
histamine receptor, subclass H1
Uniprot ID
Mouse ortholog
Hrh1 (15465)
histamine H1 receptor (Q91XN3)
Alternate
No data
Variants
No data
Financial
Revenue by drug
$
£
No data
Estimated US medical usage
Promethazine
+
Phenylephrine
+
Codeine
Total medical expenditures per year (USD, in millions)
Plot placeholder
Mock data
Subscribe for the real data
Number of persons purchased
Plot placeholder
Mock data
Subscribe for the real data
Number of purchases
Plot placeholder
Mock data
Subscribe for the real data
Refill frequency
Plot placeholder
Mock data
Subscribe for the real data
Price per prescription (USD)
Plot placeholder
Mock data
Subscribe for the real data
Promethazine
+
Codeine
Total medical expenditures per year (USD, in millions)
Plot placeholder
Mock data
Subscribe for the real data
Number of persons purchased
Plot placeholder
Mock data
Subscribe for the real data
Number of purchases
Plot placeholder
Mock data
Subscribe for the real data
Refill frequency
Plot placeholder
Mock data
Subscribe for the real data
Price per prescription (USD)
Plot placeholder
Mock data
Subscribe for the real data
Promethazine
+
Dextromethorphan
Total medical expenditures per year (USD, in millions)
Plot placeholder
Mock data
Subscribe for the real data
Number of persons purchased
Plot placeholder
Mock data
Subscribe for the real data
Number of purchases
Plot placeholder
Mock data
Subscribe for the real data
Refill frequency
Plot placeholder
Mock data
Subscribe for the real data
Price per prescription (USD)
Plot placeholder
Mock data
Subscribe for the real data
Promethazine
+
Meperidine
Total medical expenditures per year (USD, in millions)
Plot placeholder
Mock data
Subscribe for the real data
Number of persons purchased
Plot placeholder
Mock data
Subscribe for the real data
Number of purchases
Plot placeholder
Mock data
Subscribe for the real data
Refill frequency
Plot placeholder
Mock data
Subscribe for the real data
Price per prescription (USD)
Plot placeholder
Mock data
Subscribe for the real data
Promethazine
+
Phenylephrine
Total medical expenditures per year (USD, in millions)
Plot placeholder
Mock data
Subscribe for the real data
Number of persons purchased
Plot placeholder
Mock data
Subscribe for the real data
Number of purchases
Plot placeholder
Mock data
Subscribe for the real data
Refill frequency
Plot placeholder
Mock data
Subscribe for the real data
Price per prescription (USD)
Plot placeholder
Mock data
Subscribe for the real data
Promethazine
Total medical expenditures per year (USD, in millions)
Plot placeholder
Mock data
Subscribe for the real data
Number of persons purchased
Plot placeholder
Mock data
Subscribe for the real data
Number of purchases
Plot placeholder
Mock data
Subscribe for the real data
Refill frequency
Plot placeholder
Mock data
Subscribe for the real data
Price per prescription (USD)
Plot placeholder
Mock data
Subscribe for the real data
Tabular view
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 7,141 documents
View more details
Safety
Black-box Warning
Black-box warning for: Promethazine hci, Promethazine hcl, phenylephrine hcl, codeine phosphate, Promethazine hydrochloride and codeine phosphate, Promethazine hydrochloride and dextomethorphan hydrobromide, Promethazine hydrochloride, phenylephrine hydrochloride and codeine phosphate, Promethazine hydrochloride, phenylephrine hydrochloride, and codeine phosphate, Promethazine vc with codeine oral solution, Promethazine with codeine, Promethazine with codeine cough, Promethazine/codeine, Promethegan
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
16,098 adverse events reported
View more details
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use